Unveiling Breakthroughs from Rare Diseases to AI-Enhanced Insomnia Solutions

👋🏼 Healthcare Innovators ❤️

👉🏼 Here in case you missed last week edition: Advancing Health Outcomes Through Technology. Leveraging Data, AI, and Connected Care to Improve Patient Care

Sponsor Pulse Disruption | New Here? Subscribe! | Post in our Job Board 

🌐 Healthcare | News

Rare Disease Revolution: Pharma's Shift Toward Orphan Drugs Reshapes Drug Development Landscape

Pharmaceutical companies are increasingly focusing on developing treatments for rare diseases, constituting half of new drug approvals annually. The surge is attributed to the Orphan Drug Act of 1983, incentivizing research for diseases affecting up to 30 million Americans. The legislation provides incentives such as seven years of market exclusivity, waiver of user fees, and a 50% tax credit for qualifying clinical trial fees. While critics argue the act may lead to overemphasis and high costs, supporters highlight its success in preventing deaths from rare diseases. Challenges remain, with 6,500 rare diseases lacking FDA-approved treatments. Read More

After Decades of Frustration, Cures for Autoimmune Diseases Seem Possible

Scientists are exploring new ways to restore immune tolerance and tame rogue cells driving autoimmunity, offering hope after years of failed attempts. Approaches include nanoparticles to flip a "master switch", liver-targeting antigens, engineered T cells, and CAR T therapies that wipe out only culprit B cells.

Immunologist Jeffrey Hubbell: "What was so exciting about this paper is that animals had advanced disease, yet treating with just one antigen worked." Researcher Aimee Payne calls her B cell-targeting CAAR T cells "a laser, targeting the autoreactive B cells that are causing disease." But Jeffrey Bluestone cautions "these are living drugs...there's a lot we still need to learn." After decades of disappointment, experts urge cautious optimism, noting success will require unraveling complex mechanisms. Read More

Kallisio's 3D Printed Oral Stent for Cancer Care Receives FDA Clearance

Medical device company Kallisio has received FDA 510(k) clearance for its Stentra, a customized 3D printed oral stent designed to protect healthy tissue during radiation therapy for head and neck cancer patients. Stentra aims to reduce toxicity risks and enhance targeting by immobilizing organs at risk like the tongue within each patient's unique anatomy.

Stentra was co-developed with MD Anderson Cancer Center and will be rolled out through collaborations with US cancer centers. Kallisio CEO Rajan Patel said the clearance is an exciting milestone in improving patient experiences through personalized stents made in under 5 days. It demonstrates the growing role of 3D printing in advancing cancer care, from bioprinted tumor models to facial transplants. Read More

💰  Healthcare | Startups

IMU Biosciences Raises $14.6M to Advance AI-Powered Immune Profiling

UK biotech IMU Biosciences has raised $14.6 million in a Series A round led by Molten Ventures. IMU is developing CytAtlas, an AI and deep immune profiling platform providing insights into the human immune system. CytAtlas is being applied across immune-oncology, cell therapy, and more for patient stratification, disease monitoring, and diagnostics. CEO Dr. Adam Laing said the funding will advance CytAtlas and operations, noting "Our goal is to revolutionize precision medicine, improving its effectiveness and reducing failure rates." The immune profiling platform has garnered pharma interest and could enable better outcomes, cost reductions, and strategic partnerships. Read More

Ambience Healthcare Raises $70M to Scale AI for Healthcare

Ambience Healthcare, developer of an AI operating system for healthcare organizations, has raised a $70 million Series B round co-led by Kleiner Perkins and OpenAI Startup Fund. Ambience's suite of AI applications aims to reduce clinician burnout, improve efficiency, and enable high-quality care across specialties. Products include medical scribing, coding assistance, patient education, and more.

The raise comes amid rapid growth, with major health systems adopting Ambience, which seamlessly integrates with EMRs like Epic and Cerner. The technology is customized by specialty leading to high clinician adoption, time savings up to 78%, and 5x ROI. Investors were attracted to Ambience's comprehensive platform approach, spanning the care continuum from patient intake through back-office operations. The funding will further accelerate Ambience's product roadmap and dedicated teams for partners as it looks to scale its AI foundation models. Read More

Stellar Sleep Secures $6M to Transform Chronic Insomnia Treatment with Innovative Digital Solution

Stellar Sleep, a startup addressing chronic insomnia through a digital tool, secured $6 million in seed funding. Founders George Wang and Edrei Chua, who faced a six-month waitlist for sleep clinician assistance, developed an app based on sleep therapy, emphasizing psychological treatment over medication. The app, priced at $60 per month, utilizes cognitive behavior therapy and other techniques to break the cycle of chronic insomnia. Clinical assessments revealed it to be 50% more effective than sleeping pills. The funding, led by Initialized Capital, will aid in expanding content, clinician partnerships, and enhancing personalization for users. Read More

🕰️ Blasts from the Past | This Week in Medical History

February 6, 2001: Human Genome Project Completes Mapping. On this day, the Human Genome Project announced the successful mapping of the entire human genome, a groundbreaking achievement that laid the foundation for advances in personalized medicine.

February 8, 2006: First Full Face Transplant Successfully Completed. Surgeons in France carried out the world's first full face transplant on this date, marking a significant advancement in reconstructive surgery and offering new hope to patients with severe facial deformities.

February 10, 2011: IBM's Watson Debuts in Healthcare. IBM's supercomputer, Watson, made its debut in the healthcare sector by assisting in the diagnosis and treatment of a patient at Memorial Sloan Kettering Cancer Center, showcasing the potential of artificial intelligence in medicine.

February 7, 2014: FDA Approves First Bionic Eye Implant. The U.S. Food and Drug Administration (FDA) granted approval for the Argus II Retinal Prosthesis System, the first bionic eye implant, designed to restore partial vision to individuals with retinitis pigmentosa.

February 12, 2018: Amazon, Berkshire Hathaway, and JPMorgan Chase Announce Health Venture. Three major corporations, Amazon, Berkshire Hathaway, and JPMorgan Chase, announced a joint venture aimed at disrupting the healthcare industry and improving healthcare services for their employees.

February 11, 2020: World Health Organization Names Coronavirus Disease COVID-19. The World Health Organization officially named the novel coronavirus disease "COVID-19" to provide a standardized and non-stigmatizing name for the illness that would later become a global pandemic.

🧠 Healthcare | AI

Limited AI Implementation in Medical Imaging Despite Potential

A recent survey by Sermo found only 21% of healthcare leaders have integrated AI into medical imaging, though 62% expect to in the next 5 years. Adoption lags despite excitement about AI's capabilities to aid workflow and staffing challenges. 42% noted significant imaging staff shortages. 79% of FDA-cleared AI products are in radiology, showing the field's dominance. 38% of leaders have invested in radiology AI or plan to, while 32% have not. As healthcare grapples with workforce strains, broader AI implementation could provide relief, especially in imaging. But integration remains limited for now, representing an opportunity if execution barriers can be addressed. Read More

CARPL Raises $6M to Build Radiology AI Marketplace

CARPL, a startup creating an AI marketplace for radiology, has raised $6M in seed funding led by Stellaris Venture Partners. CARPL's platform allows radiologists to access, evaluate, and integrate AI tools from over 50 developers offering 100+ apps. Users include Singapore Government hospitals, Mass General, and Radiology Partners. CARPL aims to create "super-radiologists" who are 10x more productive with the aid of AI. The funds will expand CARPL's team and tech as it works to close the gap between rising imaging volume and limited radiologists. CARPL provides a unified interface so radiologists can easily reject or refine AI outputs. The seed round positions CARPL to further democratize radiology through strategic AI adoption. Read More

Nuance Integrates AI Documentation Assistant into Epic EHR

Nuance has announced the full integration of its AI-powered clinical documentation tool, Dragon Ambient eXperience (DAX) Copilot, into the Epic electronic health record (EHR) system. DAX Copilot can draft clinical notes and document patient visits in Epic's mobile app, reducing administrative burden for clinicians. Over 150 hospitals now use DAX Copilot in Epic workflows. Clinicians report the AI assistant cuts documentation time by 50%, increases patients seen per day, and reduces burnout. Patients also respond positively to the AI-powered conversational interactions during visits. The collaboration between Nuance, Epic, and Microsoft accelerated innovation to embed DAX Copilot in the EHR in under 6 months, signaling a new era of rapid advancement of AI tools to enhance clinician experiences. Read More

🗣️ Healthcare | Conferences | February

Feb. 6-7: Digital Healthcare Innovation Summit (West Coast - La Jolla, California)

Feb. 11-14: AHA Rural Health Care Leadership Conference (Orlando, Florida)

Feb. 25-28: ViVE 2024 (Los Angeles)

Feb. 27-29: America's Health Insurance Plans 2024 Executive Leadership Summit (Phoenix)

That’s all for this week.
The Pulse Disruption Team

1